Patient outcomes that support responsible catalog adoption.
We measure success through recovery, metabolic, and longevity protocol results, operating transparently so providers, partners, and patients all benefit from the same Grove formulas.
Partner Site Outcomes Summary
In a recent analysis across 850+ provider partner sites, Grove peptides demonstrated meaningful support for recovery, metabolic protocols, and partner reorder compared with baseline practice metrics.
- Improved recovery reports patients reporting better recovery support vs. baseline.
- 92% protocol continuation metabolic programs still on protocol at 12 weeks.
- 87% partner reorder catalog reorder within 90 days of first order.
